Adele M. Gulfo - 05 Nov 2021 Form 4 Insider Report for Myovant Sciences Ltd.

Role
Director
Signature
/s/ Matthew Lang, Attorney-in-fact
Issuer symbol
N/A
Transactions as of
05 Nov 2021
Net transactions value
$0
Form type
4
Filing time
09 Nov 2021, 16:36:10 UTC
Previous filing
17 Sep 2021
Next filing
16 Dec 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MYOV Stock Option (Right to Buy) Award $0 +21,096 $0.000000 21,096 05 Nov 2021 Common Shares 21,096 $22.71 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 100% of the shares underlying the option vest and become exercisable on the earlier of (a) November 5, 2022, and (b) the date that is one day prior to the Issuer's 2022 Annual General Meeting of Shareholders, subject to the Reporting Person providing continuous service to the Issuer on such date.